Back to search
FDAFDA · Food and drugs·Recall number D-0341-2019

Advanced Protection Sunscreen spf 30 (Octinoxate 7.5%, Octisalate 5%, Oxybenzone 6%), 4.5 Oz/127.5 g tube.

Published December 26, 2018 · Recall initiated: December 10, 2018

Summary

FDA records drug Class III recall D-0341-2019, published December 26, 2018 and initiated December 10, 2018. Recalling firm: CBI Laboratories, Inc.; Status: Terminated; Reported quantity: 5363 tubes; Lot: Lot #: 131965, Exp 12/2018; 127426 Exp. 01/2019; 129045, 130424 Exp. 06/2019; 130432 Exp. 10/2019; 131870 Exp. 06/2019; 132648, Exp. 03/2020; 133732 Exp. 04/2020; 134400 Exp. 02/2020; 135345 Exp. 08/2020. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug:Out of specification for percentage of active pharmaceutical ingredients.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
CBI Laboratories, Inc.
Distributor
United States, Maldives, Canada, United Arab Emirates, and New Zealand
Lot
Lot #: 131965, Exp 12/2018; 127426 Exp. 01/2019; 129045, 130424 Exp. 06/2019; 130432 Exp. 10/2019; 131870 Exp. 06/2019; 132648, Exp. 03/2020; 133732 Exp. 04/2020; 134400 Exp. 02/2020; 135345 Exp. 08/2020
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Advanced Protection Sunscreen spf 30 (Octinoxate 7.5%, Octisalate 5%, Oxybenzone 6%), 4.5 Oz/127.5 g tube. recalled?

Yes. FDA published recall D-0341-2019 on December 26, 2018. Reported hazard: Subpotent Drug:Out of specification for percentage of active pharmaceutical ingredients.

What should I do if I have this product?

Voluntary: Firm initiated · Letter